5 mg/ml
Trade Name
MOVAPO
Solution for infusion in cartridge
Request Type
New Registration
Drug Type
NCE
Approval Date
SFDA Approved Use
The treatment of motor fluctuations (‘on-off’ phenomena) in patients with Parkinson’s disease, which are not sufficiently controlled by oral anti-Parkinson medication.